In 2020.0 INT J NANOMED published article about EPIDEMIOLOGY; MATURATION; DESIGN; VIRUS; ACID; C-60 in [Huang, Hung-Jin; Hsu, Shan-hui] Natl Taiwan Univ, Inst Polymer Sci & Engn, 1,Sec 4 Roosevelt Rd, Taipei 10617, Taiwan; [Huang, Hung-Jin; Hsu, Shan-hui] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Kraevaya, Olga A.; Troshin, Pavel A.] Skolkovo Inst Sci & Technol, Moscow, Russia; [Kraevaya, Olga A.; Voronov, Ilya I.; Troshin, Pavel A.] Russian Acad Sci, Inst Problems Chem Phys, Chernogolovka 142432, Russia; [Hsu, Shan-hui] Natl Taiwan Univ, Res & Dev Ctr Med Devices, Taipei, Taiwan in 2020.0, Cited 43.0. The Name is Methyl 3-phenylpropionate. Through research, I have a further understanding and discovery of 103-25-3. HPLC of Formula: C10H12O2
Background: Nanotechnology-based strategies in the treatment of cancer have potential advantages because of the favorable delivery of nanoparticles into tumors through porous vasculature. Materials and Methods: In the current study, we synthesized a series of water-soluble fullerene derivatives and observed their anti-tumor effects on human lung carcinoma A549 cell lines. The quantitative structure-activity relationship (QSAR) modeling was employed to investigate the relationship between anticancer effects and descriptors relevant to peculiarities of molecular structures of fullerene derivatives. Results: In the QSAR regression model, the evaluation results revealed that the determination coefficient r(2) and leave-one-out cross-validation q(2) for the recommended QSAR model were 0.9966 and 0.9246, respectively, indicating the reliability of the results. The molecular modeling showed that the lack of chlorine atom and a lower number of aliphatic single bonds in saturated hydrocarbon chains may be positively correlated with the lung cancer cytotoxicity of fullerene derivatives. Synthesized water-soluble fullerene derivatives have potential functional groups to inhibit the proliferation of lung cancer cells. Conclusion: The guidelines obtained from the QSAR model might strongly facilitate the rational design of potential fullerene-based drug candidates for lung cancer therapy in the future.
About Methyl 3-phenylpropionate, If you have any questions, you can contact Huang, HJ; Kraevaya, OA; Voronov, II; Troshin, PA; Hsu, SH or concate me.. HPLC of Formula: C10H12O2
Reference:
Patent; SANOFI; US2011/294788; (2011); A1;,
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics